| 10.04.2024 10:48 | ETX | e-Therapeutics says company faces lack of interest as UK listing | Alliance |
| 10.04.2024 07:00 | ETX | Proposed Fundraise of £28.9m and Cancellation | RNS |
| 31.01.2024 16:30 | ETX | Total Voting Rights | RNS |
| 24.01.2024 10:04 | ETX | Exercise of Options and Issue of Equity | RNS |
| 16.01.2024 10:34 | ETX | IN BRIEF: e-Therapeutics shares rise on strong financial year | Alliance |
| 16.01.2024 07:00 | ETX | Business Update | RNS |
| 09.01.2024 16:04 | ETX | Director Dealing and Issue of Equity | RNS |
| 27.12.2023 10:27 | ETX | IN BRIEF: e-Therapeutics shares to cease trading on OTCQX | Alliance |
| 27.12.2023 07:00 | ETX | Update on OTCQX Market Listing | RNS |
| 13.11.2023 09:05 | ETX | Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery | EQS |
| 02.11.2023 14:34 | STK, ETX, OHT | EARNINGS AND TRADING: Kanabo inks CBD deal, Taseko boosts production | Alliance |
| 02.11.2023 07:00 | ETX | Strategic RWE collaboration with Arcturis | RNS |
| 26.10.2023 18:12 | ETX, HAYD, SCF | EARNINGS: Riverstone Credit stays stable, Bloomsbury hails record half | Alliance |
| 26.10.2023 07:38 | ETX | Interim results for the six months to 31 July 2023 | RNS |
| 19.10.2023 15:46 | WPP, ULVR, STAN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 19.10.2023 09:54 | ETX | Notice of Interim Results | RNS |
| 29.09.2023 16:30 | ETX | Total Voting Rights | RNS |
| 20.09.2023 14:37 | GENF, ETX, UJO | TRADING UPDATES: Capital inks contract; Lansdowne becomes cash shell | Alliance |
| 20.09.2023 07:00 | ETX | Senior Management Update | RNS |
| 07.09.2023 11:47 | ETX | Exercise of Options and Issue of Equity | RNS |
| 31.07.2023 16:30 | ETX | Total Voting Rights | RNS |
| 18.07.2023 16:20 | ETX | Result of Annual General Meeting | RNS |
| 11.07.2023 15:45 | WSP, SML, SMRT | UK shareholder meetings calendar - next 7 days | Alliance |
| 06.07.2023 17:27 | ETX | Director Dealing and Issue of Equity | RNS |
| 30.06.2023 07:00 | ETX | Investor Presentation | Reach |
| 26.06.2023 07:00 | ETX | Notice of Investor Presentation | Reach |
| 11.05.2023 07:00 | ETX | Notice of AGM and Posting of Annual Report | RNS |
| 04.05.2023 19:37 | ETX, HSD, POLN | TRADING UPDATES: Virgin Wines warns sales will be below City forecasts | Alliance |
| 04.05.2023 07:00 | ETX | Final results for the year ended 31 January 2023 | RNS |
| 28.04.2023 16:30 | ETX | Total Voting Rights | RNS |
| 27.04.2023 15:48 | WPM, VMUK, TRN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 27.04.2023 07:00 | ETX | Notification of Full Year Results Date | RNS |
| 28.03.2023 15:57 | ETX | Exercise of Options and Issue of Equity | RNS |
| 21.02.2023 16:35 | ETX | Price Monitoring Extension | RNS |
| 20.02.2023 10:19 | ETX | Director/PDMR Shareholding | RNS |
| 07.02.2023 19:37 | LOK, ETX, WTAN | TRADING UPDATES: Ormonde Mining acquires stake in Peak Nickel | Alliance |
| 07.02.2023 07:00 | ETX | Filing of four patent applications | RNS |
| 31.01.2023 07:00 | ETX | Total Voting Rights | RNS |
| 04.01.2023 15:15 | ETX | Director Dealing and Issue of Equity | RNS |
| 29.12.2022 16:40 | ETX | Second Price Monitoring Extn | RNS |
| 29.12.2022 16:35 | ETX | Price Monitoring Extension | RNS |
| 20.12.2022 16:35 | ETX | Price Monitoring Extension | RNS |
| 31.10.2022 07:00 | ETX | Total Voting Rights | RNS |
| 12.10.2022 15:12 | ETX | Holding(s) in Company | RNS |
| 11.10.2022 10:42 | ETX | Holding(s) in Company | RNS |
| 10.10.2022 08:03 | MNG, ETX | Holding(s) in Company | RNS |
| 30.09.2022 12:15 | ETX | e-Therapeutics shares up on GBP13.5 million subscription; loss widens | Alliance |
| 30.09.2022 07:00 | ETX | Interim results for the six months to 31 July 2022 | RNS |
| 30.09.2022 07:00 | ETX | Fundraise of £13.5 million by way of Subscription | RNS |
| 26.09.2022 16:40 | ETX | Second Price Monitoring Extn | RNS |
| 26.09.2022 16:36 | ETX | Price Monitoring Extension | RNS |
| 01.08.2022 17:43 | ETX | IN BRIEF: e-Therapeutics files patent applications for GalNAc-siRNA | Alliance |
| 01.08.2022 07:00 | ETX | Filing of eight patent applications | RNS |
| 29.07.2022 07:00 | ETX | Total Voting Rights | RNS |
| 20.07.2022 10:39 | ETX | Result of Annual General Meeting | RNS |
| 12.07.2022 15:39 | WSP, TENG, NXR | UK shareholder meetings calendar - next 7 days | Alliance |
| 06.07.2022 07:00 | ETX | Notice to Shareholders - AGM Virtual Access | RNS |
| 05.07.2022 07:00 | ETX | Director Dealing and Issue of Equity | RNS |
| 17.05.2022 07:00 | ETX | Notice of AGM and Posting of Annual Report | RNS |
| 04.05.2022 14:11 | ETX | IN BRIEF: e-Therapeutics doubles annual loss as research costs surge | Alliance |
| 04.05.2022 07:00 | ETX | Final results for the year ended 31 January 2022 | RNS |
| 27.04.2022 16:08 | UKCM, TRB, SNWS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 27.04.2022 07:00 | ETX | Notification of Full Year Results Date | RNS |
| 12.04.2022 21:28 | FDBK, ETX, MSMN | TRADING UPDATES: Hornby sales rise; Victoria weathers inflation | Alliance |
| 12.04.2022 07:00 | ETX | Key Milestone Achieved on Galapagos Collaboration | RNS |
| 05.04.2022 21:39 | ATYM, AFRN, ETX | TRADING UPDATES: Alpha FX restarts relationship; Atalaya resources up | Alliance |
| 05.04.2022 07:00 | ETX | Immuno-Oncology Research Collaboration with iTeos | RNS |
| 16.02.2022 16:41 | ETX | Holding(s) in Company | RNS |
| 16.02.2022 11:47 | ETX | Holding(s) in Company | RNS |
| 15.02.2022 15:27 | ETX | Holding(s) in Company | RNS |
| 31.01.2022 07:00 | ETX | Total Voting Rights | RNS |
| 20.01.2022 10:58 | ETX | New Corporate Website | Reach |
| 18.01.2022 16:41 | ETX | Holding(s) in Company | RNS |
| 07.01.2022 07:00 | ETX | Director Dealing and Issue of Equity | RNS |
| 22.11.2021 07:00 | ETX | Senior Management Update | RNS |
